You have 9 free searches left this month | for more free features.

Condition

Lymphoma, Follicular (1)

Lymphoma, Mantle-Cell (1)

Multiple Myeloma (1)

Myelodysplastic Syndromes (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

Sponsor

Celgene (2)

Collaborator

Intervention

revlimid® (2)

dexamethasone (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Observational (2)

revlimid®

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk

Recruiting

Myelodysplastic Syndromes
+2 more

REVLIMID®

Anyang, Korea, Republic of
+12 more

Apr 6, 2021

Efficacy Information of Korean Multiple Myeloma Patients Treated

Completed

Multiple Myeloma

REVLIMID®
Dexamethasone

Anyang, Korea, Republic of
+24 more

Nov 30, 2017